Skip to main content
Bonesupport Holding logo

Bonesupport Holding — Investor Relations & Filings

Ticker · BONEX ISIN · SE0009858152 LEI · 549300COLY053IGTLD63 ST Manufacturing
Filings indexed 449 across all filing types
Latest filing 2019-07-31 Share Issue/Capital Cha…
Country SE Sweden
Listing ST BONEX

About Bonesupport Holding

https://www.bonesupport.com/en-eu/

Bonesupport Holding is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes. Its core product platform, CERAMENT®, is an innovative range of osteoconductive and drug-eluting products designed to heal bone defects. A key characteristic of CERAMENT® is its ability to remodel into the patient's own host bone, typically within six to twelve months. The products are used to treat bone voids and defects arising from trauma, infection, disease, or related surgical procedures. The radiopaque nature of the material allows for visualization during and after surgery.

Recent filings

Filing Released Lang Actions
Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)
Share Issue/Capital Change Classification · 1% confidence The document explicitly announces a 'Change in number of shares and votes' due to the exercise of warrants, detailing the new total number of ordinary shares and series C shares, and the resulting total number of votes as of July 31, 2019. This directly relates to changes in the company's capital structure or share count. This aligns best with the 'Share Issue/Capital Change' definition (SHA). It is not a general earnings release (ER), a dividend notice (DIV), or a director's dealing report (DIRS). Since it is a specific announcement about share count changes, SHA is the most precise fit over the general 'Regulatory Filings' (RNS). The document length is short, but it contains the core information, not just an announcement of an attached report.
2019-07-31 English
BONESUPPORT HOLDING AB (publ) – Publicerar Q2 2019 delårsrapport
Earnings Release Classification · 1% confidence The document provides a detailed financial summary for the period April - June 2019 and January - June 2019, including key figures like Net Sales, Gross Margin, Operating Result, and Earnings Per Share. It features a CEO commentary section titled 'SOLID LEVERANS AV STRATEGIN – GOD TILLVÄXT I KVARTALET' and segmented performance breakdowns (North America and EUROW). This structure, covering a specific fiscal quarter and half-year with detailed financial metrics and management discussion, strongly indicates an Interim/Quarterly Report. The language is Swedish, but the content aligns perfectly with the definition of an Interim Report (IR). It is not a full Annual Report (10-K) as it covers only half a year, nor is it just an Earnings Release (ER) as it contains extensive operational detail and segment analysis beyond just highlights. It is also not an announcement of a report (RPA) as the full data is present. Q2 2019
2019-07-25 Swedish
BONESUPPORT HOLDING AB (publ) – Publishes Q2 2019 Interim report
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for the period of April-June 2019 (Q2) and January-June 2019 (H1). It contains detailed financial statements, key figures, management commentary, segment analysis (North America and EUROW), and research and development updates. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report. Q2 2019
2019-07-25 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive quarterly financial report for BONESUPPORT for the period April-June 2019. It contains detailed financial statements, key performance indicators (KPIs), management commentary (VD KOMMENTERAR), segment analysis (North America and EUROW), and research and development updates. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis, thus fitting the definition of an Interim/Quarterly Report. Q2 2019
2019-07-25 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for the period of April-June 2019 (Q2) and January-June 2019 (H1). It contains detailed financial statements, key figures, management commentary, segment analysis (North America and EUROW), and research and development updates. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report. Q2 2019
2019-07-25 English
Item affecting comparability in Q2 2019
Earnings Release Classification · 1% confidence The document is a short press release dated July 19, 2019, announcing a specific financial event: a provision of SEK 11.0 million recorded as an 'item affecting comparability' in Q2 2019 related to product returns from a former distributor (Zimmer Biomet). It provides key financial highlights and context regarding a past distribution agreement termination. This format—a brief, immediate announcement of key financial results or material events outside of a full quarterly report (IR) or annual report (10-K)—is characteristic of an Earnings Release (ER). It is not a full transcript (CT), a management discussion (MDA), or a general regulatory filing (RNS), as it focuses specifically on the financial outcome for the period. Q2 2019
2019-07-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.